Charles River reopening preclinical site; Illumina dives into consumer genomics;

> Charles River Laboratories ($CRL) is planning to reopen a preclinical research outpost it closed in 2010, citing an increase in demand for early-stage services. News

> Sequencing giant Illumina ($ILMN) recruited Warburg Pincus, the Mayo Clinic and Sutter Hill Ventures to launch Helix, a consumer genomics company setting sail with $100 million from its founders. More

Suggested Articles

Dubbed “Project Nightingale,” the efforts were announced amid concerns and federal inquiries into the data’s safekeeping and patient consent for use.

Independent site management organization Panthera Biopartners has kick-started its first clinical trial in the U.K.

WIRB-Copernicus Group’s clinical services division bought out trial consultancy firm Waife & Associates as it looks to boost its management services.